Revenue, 2025
USD 25.62 Bn
Forecast Year, 2034
USD 83.79 Bn
CAGR, 2025 - 2034
14.15%
Report Coverage
Worldwide
The global genotyping market, valued at USD 25.62 billion in 2025, is projected to reach USD 83.79 billion by 2034, growing at a CAGR of 14.15%, driven by advancements in genetic research, personalized medicine, and high-throughput technologies.
Genotyping Market Size Analysis
Genotyping Market Size Product 2025 to 2034 (USD Billion)
| Product | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Instruments | 1.35 | 1.51 | 1.75 | 2.00 | 2.32 | 2.59 | 2.89 | 3.29 | 3.68 | 4.31 |
| Sequencers & Amplifiers | 2.88 | 3.21 | 3.69 | 4.20 | 4.88 | 5.50 | 6.30 | 7.22 | 8.09 | 9.26 |
| Analyzers | 3.28 | 3.71 | 4.26 | 4.92 | 5.69 | 6.49 | 7.37 | 8.20 | 9.19 | 10.35 |
| Reagents & Kits | 3.34 | 3.84 | 4.36 | 5.07 | 5.87 | 6.62 | 7.74 | 8.75 | 9.73 | 11.00 |
| Software and Services | 5.05 | 5.88 | 6.78 | 7.85 | 8.81 | 9.88 | 11.06 | 12.67 | 14.80 | 16.87 |
| Genotyping Services | 9.72 | 11.11 | 12.53 | 14.07 | 15.94 | 18.57 | 21.33 | 24.56 | 28.36 | 32.53 |
Genotyping Market Size Application 2025 to 2034 (USD Billion)
| Application | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacogenomics | 2.37 | 2.68 | 3.15 | 3.57 | 4.18 | 4.83 | 5.58 | 6.41 | 7.50 | 8.52 |
| Diagnostics and Personalized Medicine | 2.80 | 3.11 | 3.51 | 4.08 | 4.76 | 5.23 | 6.09 | 6.96 | 7.80 | 9.06 |
| Agricultural Biotechnology | 6.57 | 7.49 | 8.55 | 9.70 | 11.03 | 12.42 | 13.97 | 15.70 | 17.50 | 20.23 |
| Animal Genetics | 6.81 | 7.88 | 8.99 | 10.33 | 11.54 | 13.39 | 15.47 | 17.79 | 20.49 | 23.01 |
| Others | 7.06 | 8.09 | 9.19 | 10.42 | 11.99 | 13.78 | 15.57 | 17.85 | 20.57 | 23.49 |
Genotyping Market Size Technology 2025 to 2034 (USD Billion)
| Technology | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| PCR | 1.93 | 2.20 | 2.48 | 2.80 | 3.19 | 3.58 | 4.03 | 4.69 | 5.26 | 5.96 |
| Capillary Electrophoresis | 1.96 | 2.25 | 2.60 | 2.93 | 3.46 | 3.94 | 4.49 | 5.06 | 5.91 | 6.65 |
| Microarrays | 4.46 | 5.08 | 5.67 | 6.57 | 7.45 | 8.54 | 9.69 | 11.21 | 12.79 | 14.50 |
| Sequencing | 4.51 | 5.14 | 5.72 | 6.67 | 7.55 | 8.71 | 10.03 | 11.45 | 12.86 | 14.83 |
| Matrix-Assisted Laser Desorption | 5.60 | 6.45 | 7.39 | 8.34 | 9.68 | 10.94 | 12.42 | 14.00 | 15.93 | 17.95 |
| Others | 7.17 | 8.13 | 9.52 | 10.81 | 12.18 | 13.94 | 16.03 | 18.28 | 21.11 | 24.42 |
Genotyping Market Size End User 2025 to 2034 (USD Billion)
| End User | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Pharmaceutical And Biopharmaceutical Companies | 4.85 | 5.36 | 6.06 | 6.97 | 8.05 | 9.42 | 10.48 | 12.25 | 14.14 | 16.19 |
| Diagnostics And Research Laboratories | 5.95 | 6.65 | 7.62 | 8.74 | 10.01 | 11.27 | 13.22 | 15.00 | 17.28 | 19.43 |
| Academic Institutes | 5.98 | 6.98 | 8.13 | 9.03 | 10.09 | 11.77 | 13.80 | 15.71 | 17.95 | 20.61 |
| Others | 8.84 | 10.27 | 11.57 | 13.37 | 15.35 | 17.19 | 19.18 | 21.74 | 24.49 | 28.09 |
Genotyping Market Size Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 1.55 | 1.79 | 2.08 | 2.38 | 2.69 | 3.03 | 3.41 | 4.00 | 4.65 | 5.46 |
| Europe | 3.27 | 3.74 | 4.30 | 4.80 | 5.42 | 6.17 | 7.22 | 8.38 | 9.82 | 10.92 |
| Asia Pacific | 5.45 | 6.20 | 7.17 | 8.30 | 9.72 | 10.91 | 12.23 | 14.10 | 16.42 | 18.71 |
| Latin America | 5.76 | 6.51 | 7.32 | 8.51 | 9.90 | 11.35 | 13.19 | 15.00 | 16.70 | 19.12 |
| Middle East and Africa | 9.59 | 11.01 | 12.52 | 14.12 | 15.77 | 18.19 | 20.63 | 23.22 | 26.27 | 30.10 |
Genotyping Market Size to Touch USD 83.79 Billion by 2034
The global genotyping market size was calculated at USD 25.62 billion in 2025 and is predicted to attain around USD 83.79 billion by 2034 a CAGR of 14.15%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com